메뉴 건너뛰기




Volumn 52, Issue 6, 2010, Pages 2242-2242

Liver enzymes and cardiovascular outcomes: A new research agenda

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYTOKERATIN 18; GAMMA GLUTAMYLTRANSFERASE;

EID: 78649613803     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23825     Document Type: Letter
Times cited : (1)

References (9)
  • 1
    • 77956631214 scopus 로고    scopus 로고
    • Liver enzymes, NAFLD and incident cardiovascular disease: a narrative review and clinical perspective of prospective data
    • ; doi:10.1002/hep.23789
    • Ghouri N, Preiss D, Sattar N. Liver enzymes, NAFLD and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. HEPATOLOGY 2010; doi:10.1002/hep.23789.
    • (2010) HEPATOLOGY
    • Ghouri, N.1    Preiss, D.2    Sattar, N.3
  • 2
    • 33745592823 scopus 로고    scopus 로고
    • The metabolic syndrome: is this diagnosis necessary?
    • Reaven G. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006; 83: 1248-1251.
    • (2006) Am J Clin Nutr , vol.83 , pp. 1248-1251
    • Reaven, G.1
  • 3
    • 34247193564 scopus 로고    scopus 로고
    • Metabolic syndrome: is it a syndrome? Does it matter?
    • Kahn R. Metabolic syndrome: is it a syndrome? Does it matter? Circulation 2007; 115: 1806-1810.
    • (2007) Circulation , vol.115 , pp. 1806-1810
    • Kahn, R.1
  • 4
    • 24944493252 scopus 로고    scopus 로고
    • The myth of the metabolic syndrome
    • Gale EA. The myth of the metabolic syndrome. Diabetologia 2005; 48: 1679-1683.
    • (2005) Diabetologia , vol.48 , pp. 1679-1683
    • Gale, E.A.1
  • 6
    • 78649569681 scopus 로고    scopus 로고
    • Liver function tests: association with cardiovascular outcomes
    • Yilmaz Y. Liver function tests: association with cardiovascular outcomes. World J Hepatol 2010; 2: 143-145.
    • (2010) World J Hepatol , vol.2 , pp. 143-145
    • Yilmaz, Y.1
  • 7
    • 51349083814 scopus 로고    scopus 로고
    • Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes
    • Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. HEPATOLOGY 2008; 48: 792-798.
    • (2008) HEPATOLOGY , vol.48 , pp. 792-798
    • Fracanzani, A.L.1    Valenti, L.2    Bugianesi, E.3    Andreoletti, M.4    Colli, A.5    Vanni, E.6
  • 8
    • 70350747448 scopus 로고    scopus 로고
    • Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease
    • Yilmaz Y. Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease. Aliment Pharmacol Ther 2009; 30: 1103-1109.
    • (2009) Aliment Pharmacol Ther , vol.30 , pp. 1103-1109
    • Yilmaz, Y.1
  • 9
    • 57349143814 scopus 로고    scopus 로고
    • Implications of elevated serum alanine aminotransferase levels: think outside the liver
    • Ioannou GN. Implications of elevated serum alanine aminotransferase levels: think outside the liver. Gastroenterology 2008; 135: 1851-1854.
    • (2008) Gastroenterology , vol.135 , pp. 1851-1854
    • Ioannou, G.N.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.